...
首页> 外文期刊>JAMA surgery >Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer Alliance for Clinical Trials in Oncology Trial A021101
【24h】

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer Alliance for Clinical Trials in Oncology Trial A021101

机译:术前改良FOLFIRINOX治疗,随后以卡培他滨为基础的化学放疗用于边界可切除胰腺癌肿瘤临床试验的临床联盟A021101

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

IMPORTANCE Although consensus statements support the preoperative treatment of borderline resectable pancreatic cancer, no prospective, quality-controlled, multicenter studies of this strategy have been conducted. Existing studies are retrospective and confounded by heterogeneity in patients studied, therapeutic algorithms used, and outcomes reported.
机译:重要提示尽管共识性声明支持可切除的交界性胰腺癌的术前治疗,但尚未对此策略进行前瞻性,质量控制,多中心研究。现有研究是回顾性的,并因所研究患者的异质性,所使用的治疗算法和所报告的结果而混淆。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号